CeriBell, Inc. CBLL
Set alert
26.96 USD +0.38 +1.43%
At close · Nov 2
26.96 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
26.82 Day range 27.54
10.85 52-week range 28.19
- YTD
- +22.94%
- 1 year
- +136.49%
- Open
- 26.96
- Prev close
- 26.58
- Mkt cap
- 1.03B
- Vol
- 912.65K
- Avg vol
- 437.25K
- EPS
- -1.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.82
- High
- 27.54
- Forward P/E
- -16.71
- Beta
- 0.86
- Short ratio
- 5.05
- Inst. own
- 90.78%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 24.92
- 200-d avg
- 20.78
- 1y target
- 28.57
3M chart
Events in this range
- Aug 10, 2026Earnings: -0.51; estimate -0.47119; surprise -8.24%
- Aug 11, 2026Rating: BTIG · Buy → Buy
- Aug 11, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 18, 2026Rating: BTIG · Buy → Buy
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Oct 2, 2026Rating: TD Cowen · Buy → Buy
Signals (15)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 21 hours ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| RSI: Overbought | Sep 4, 2026 | 1 month ago |
| RSI: Overbought | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
Financial health
Altman Z-Score
14.49 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -15.0×
FY 2022 5y median -17.8× FY 2025
P/S 9.0×
FY 2022 5y median 13.5× FY 2025
P/B 5.2×
FY 2022 5y median -0.2× FY 2025
P/FCF -19.3×
FY 2022 5y median -19.3× FY 2025
EV/EBITDA -15.6×
FY 2022 5y median -17.9× FY 2025
EV/Sales 8.8×
FY 2022 5y median 12.0× FY 2025
FCF Yield -5.2%
FY 2022 5y median -5.2% FY 2025
Profitability
Gross Margin 87.9%
FY 2022 5y median 85.6% FY 2025
Operating Margin -65.6%
FY 2022 5y median -66.0% FY 2025
Net Margin -60.0%
FY 2022 5y median -63.5% FY 2025
ROE -34.4%
FY 2022 5y median 2.5% FY 2025
ROIC -32.9%
FY 2022 5y median -39.0% FY 2025
ROA -27.3%
FY 2022 5y median -35.1% FY 2025
Growth (YoY)
Revenue 36.1%
FY 2022 FY 2025
Operating Income -47.1%
FY 2022 FY 2025
EPS (diluted) -29.2%
FY 2022 FY 2025
Free Cash Flow -14.3%
FY 2022 FY 2025
Financial Health
Current Ratio 9.7×
FY 2022 5y median 8.9× FY 2025
Quick Ratio 9.4×
FY 2022 5y median 8.5× FY 2025
Debt / Equity 0.1×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2022 5y median 1.1× FY 2025
Interest Coverage -30.9×
FY 2022 5y median -21.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31